Minireviews
Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Sep 27, 2013; 5(9): 496-504
Published online Sep 27, 2013. doi: 10.4254/wjh.v5.i9.496
Table 3 Treatment outcomes of hepatitis C virus genotype 6 by the treatment duration
Ref.Design/treatmentDuration (wk)nSVRP value
Nguyen et al[44]Retrospective242339%0.044
PEG-IFN 2a/2b + WB-RBV481275%
Lam et al[45]Randomized (1:1)242770%0.450
PEG-IFN 2a + WB-RBV483379%
Thu-Thuy et al[47]Randomized (1:2)243560%0.240
PEG-IFN 2a + WB-RBV487071%
Tangkijvanich et al[48]Prospective24 if RVR achieved2588%NR
PEG-IFN 2a + WB-RBV48 if no RVR944%